SAFENSURE™ Advanced Safety Testing Solution for Biologics

Endotoxin, mycoplasma, and sterility testing are essential elements of quality control in biologics manufacturing, serving a critical role in ensuring both regulatory compliance and patient safety.Endotoxins, which may originate from raw materials or the manufacturing environment, can trigger severe pyrogenic responses and compromise drug efficacy. The Recombinant Factor C (rFC) assay offers a highly sensitive, animal-free alternative to traditional LAL methods, using fluorescence-based detection for more accurate and consistent results.

SAFENSURE™ is a specialized safety testing solution brand developed by ACROBiosystems, aligned with major pharmacopeias, international biopharmaceutical regulations. Tailored for critical safety evaluations in biologics manufacturing workflows, SAFENSURE™ provides validated assay kits for the detection of endotoxins, mycoplasma, and sterility, helping ensure regulatory compliance and product safety throughout the biologic production process.

Core Strengths

Stable and Reliable — Stringent batch testing and release, with inter-batch variability less than 15%.

Regulatory Compliance — Compliant with standards and regulations of international regulatory agencies.

Global Supply — Product delivery in 1-3 days, worldwide.

Comprehensive Validation — Referencing guidelines including ChP, Ph. Eur. and USP.

Endotoxin Detection Platform

The recombinant Factor C (rFc) assay uses genetically engineered recombinant Factor C to bind and detect endotoxins with high sensitivity and specificity. Upon activation by endotoxin, the rFC cleaves a fluorogenic substrate, generating a fluorescence signal proportional to endotoxin levels.

Compared to conventional LAL assays, this kit provides improved accuracy, eliminates interference from Factor G pathways, and delivers more consistent, reproducible results aligned with global regulatory trends toward sustainability and animal-free testing.

Star Product—Recombinant Factor C (rFc) Endotoxin Detection Kit (Cat. No. RES-A056)

Fully validated Recombinant Factor C method (Ph. Eur. 11.0 and USP<1225> guidelines). USP<86> has officially recognized the Recombinant Factor C (rFC) assay for endotoxin detection.
High concordance with traditional LAL methods, third-party validation available.
Superior specificity: Effectively eliminates β-glucan interference.
High accuracy: Endotoxin standards traceable to USP Standard (Cat. No: 1235503).
Rapid results: Assay completion in under 2 hours.
Industry-leading sensitivity: Detects endotoxin from 0.005 - 5 EU/mL.
Excellent buffer compatibility for diverse assay systems.
Good inter batch consistency: Guaranteed by genetic recombination technology production.

Validation Data

High Sensitivity: Endotoxin detection results comparable to traditional LAL methods.
High Sensitivity: Endotoxin detection results comparable to traditional LAL methods.

Different methods were used to detect endotoxin residues in four samples, and the values of this rFc method and LAL method were at the same level.

High Sensitivity: Endotoxin detection results comparable to traditional LAL methods.

The kit is applicable in endotoxin detection of injectable drugs and some medium, such as Recombinant Human Interferon α-1b, Human insulin injection and different mediums. The results of the rFc method of this kit are compared with those of LAL method.

High Specificity
Cultivation Scheme for PBMC-Derived T Cells in 6-Well Plate System

The rFC method was employed to detect endotoxin residues in β-glucan at concentrations of 10ug/mL and 1ug/mL. No non-specific signals were detected. In contrast, the dynamic chromogenic method used for β-glucan detection resulted in the detection of endotoxin and non-specific signals. This indicates that recombinant factor C does not react with β-glucan, demonstrating the good specificity of the rFC method.

Standard Traceability
Cultivation Scheme for PBMC-Derived T Cells in 6-Well Plate System

Using Endotoxin (USP, Cat. No. U1235503) as the standard, the recovery rate of ACRO Kit standard is in the range of 50%-200%, which meets the requirements.

Mycoplasma Detection Platform

Mycoplasma contamination poses a critical risk during biologics production, particularly in processes such as cell isolation, modification, and expansion. To ensure the safety of the final product, mycoplasma must be completely excluded during release testing. ACROBiosystems’ SAFENSURE™ offers a comprehensive mycoplasma analytical reagents, including Mycoplasma DNA Sample Preparation Kit and Mycoplasma Rapid Detection Kit, developed to meet the requirements of European Pharmacopoeia Chapter 2.6.7,accelerating both biologics in-process monitoring and batch release.

Product List

Cat. No. Description Size
OPA-E101 Mycoplasma DNA Sample Preparation Kit (Magnetic beads) 50 Prep
OPA-S102 Mycoplasma Rapid Detection Kit (qPCR) 50 Tests

Star Product — Mycoplasma Rapid Detection Kit (Cat. No. OPA-S102)

Broad Coverage: Covers over 250 Mollicutes species, including all listed in EP, USP, JP.
High Specificity: Target mycoplasma 16S rRNA with no cross-reactivity to other genera.
High Sensitivity: Meets or exceeds regulatory standards of 10 CFU/mL.
Strong Compatibility: Suitable for complex matrices like high cell density samples and 10% DMSO.
Easy to use: Single-well assay format with built-in UNG and controls. results in 3 hours.
Reliable performance: Results align with culture-based methods; third-party validated by Eurofins.
Request Validation Report

Validation Data

Broad Coverage: Detects over 250 species of Mycoplasma and Spiroplasma.
Number of Mollicutes detected with a Database match
Genus No.
Mycoplasma >200
Acholeplasma 14
Spiroplasma 25
Ureaplasma 7
High Sensitivity: Meets regulatory guideline standards with a detection limit of 10 CFU/mL.
ID Mycoplasma Species Compendia requirements (CFU/mL) Results Limit (CFU/mL)
1 Mycoplasma orale 10 24/24 1
2 Mycoplasma pneumoniae 10 24/24 0.1
3 Mycoplasma hyorhinis 10 24/24 1
4 Mycoplasma salivarium 10 24/24 1
5 Mycoplasma fermentans 10 24/24 1
6 Mycoplasma synoviae 10 24/24 1
7 Mycoplasma gallisepticum 10 24/24 1
8 Mycoplasma arginini 10 24/24 1
9 Acholeplasma laidlawii 10 24/24 0.1
10 Spiroplasma citri 10 24/24 0.1
High Specificity: Unaffected by unrelated cell types or microbial strains.
Unrelated strain/Cell line Ct Value Result
Streptococcus pneumoniae Undetermined Undetermined 0/2
Lactobacillus acidophilus Undetermined Undetermined 0/2
Staphylococcus epidermidis Undetermined Undetermined 0/2
Clostridium sporogenes Undetermined Undetermined 0/2
Clostridium acetobutylicum Undetermined Undetermined 0/2
CHO(106 cells/mL) Undetermined Undetermined 0/2
HEK293(106 cells/mL) Undetermined Undetermined 0/2
T cell(107 cells/mL) Undetermined Undetermined 0/2
Pichia pastoris Undetermined Undetermined 0/2
E.coli Undetermined Undetermined 0/2
High-quality assurance with superior performance compared to other competing products.
High Quality Laminin Protein supports Clinical iPSC Banking

Sterility Detection Platform

Nucleic Acid Testing (NAT) is a powerful approach for microbial detection, offering greater sensitivity and faster results than traditional culture methods. Validated to EP 2.6.1 and USP <71>, SAFENSURE™ Sterility Rapid Detection Kit (qPCR) delivers reliable test results in just 3 hours, enables simultaneous bacteria and fungi testing—revolutionizing in-process and lot-release testing with speed and reliability.

Paired with the SAFENSURE™ Sterility Sample Preparation Kit, the kits provide an end-to-end workflow from microbial nucleic acid isolation to detection. This minimizes handling errors, simplifies operations, and accelerates sterility testing with accurate, compliant results at lower cost.

Product List

Cat. No. Description Size
OPA-E102 SAFENSURE™ Sterility Sample Preparation Kit (Magnetic beads) 16 preps
OPA-S103 SAFENSURE™ Sterility Rapid Detection Kit (qPCR) 50 Tests

Star Product — Sterility Rapid Detection Kit (Cat. No. OPA-S103)

Broad Coverage: Detects diverse microbial species, including specified in EP, USP, and ChP.
Dual Detection: Identifies bacteria and fungi in one test, simplifying sterility testing workflows.
Strong Specificity: Multiple primers and probes ensure no cross-reactivity with related strains.
High Sensitivity: Detects as low as 100 CFU/mL, fully compliant with or exceeding regulatory standards
Convenient Operation: Single-well format with all essential components included for efficient testing.
Comparable Results: Delivers results equivalent to traditional culture-based methods.
High Quality: Manufactured in a GMP-like facility under ISO 13485 standards for reliable performance.

Validation Data

High Sensitivity
Strain Species Limit (CFU/mL) Results
Bacillus spizizenii 100 10/10
Burkholderia cepacia 100 10/10
Clostridium sporogenes 100 10/10
Cutibacterium acnes 100 10/10
Escherichia coli 100 10/10
Micrococcus luteus 100 10/10
Pseudomonas aeruginosa 100 10/10
Staphylococcus aureus 100 10/10
Streptococcus pyogenes 100 10/10
Candida albicans 100 10/10
Aspergillus brasiliensis 100 10/10
Aspergillus niger 100 10/10
High Specificity
The three fluorescent channels are independent and show no crosstalk, with a precision CV ≤ 0.25% (n=10).

The three fluorescent channels are independent and show no crosstalk, with a precision CV ≤ 0.25% (n=10).

Competitive Analysis
Competitive Analysis

Resources

  • Background
  • Core Strengths
  • Endotoxin Detection Platform
  • Mycoplasma Detection Platform
  • Sterility Detection Platform
  • Resources